Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer

Abstract

Baseline bilirubin and serum proteins were not associated with the prognosis of advanced pancreatic cancer. Tumor location and level of CA19-9 may serve as significant indicators for poor prognosis in those patients.